Chief Executive Officer, Sarah Cannon

President, Clinical Operations and Chief Medical Officer, Sarah Cannon

Senior Vice President, Sarah Cannon Market Operations and Physician in Chief of Blood Cancers, Sarah Cannon

Chief Financial Officer, Sarah Cannon

Chief Information Officer, Sarah Cannon

Chief Scientific Officer; Director, Lung Cancer Research Program; Principal Investigator, Sarah Cannon Research Institute

Vice President, Human Resources, Sarah Cannon

Regional Vice President, Cancer Services for Sarah Cannon, North Florida

Executive Medical Director, Drug Development Program; Principal Investigator, Sarah Cannon Research Institute - UK

Associate Director, Drug Development; Principal Investigator, Sarah Cannon Research Institute

Director, GI Cancer Research Program; Associate Director, Drug Development Program, Sarah Cannon Research Institute

Director of Myeloma Research; Senior Investigator, Hematologic Malignancies; Principal Investigator, Sarah Cannon Research Institute

Senior Director, Clinical Operations, Sarah Cannon Research Institute

Vice President, Operations, Sarah Cannon Blood Cancer Network

VP of Clinical Operations, Sarah Cannon

Assistant Vice President, Strategy and Development, Sarah Cannon

Assistant Vice President of Operations, Sarah Cannon Blood Cancer Network

Director, Personalized Medicine Operations, Sarah Cannon

Quality Improvement Director, Sarah Cannon Blood Cancer Network

Investigator, Hematologic Malignancies; Principal Investigator, Sarah Cannon Research Institute

Assistant Vice President, Clinical Operations, Sarah Cannon

Director, Drug Development, Sarah Cannon Research Institute at HealthONE

Director, Blood Cancer Research Program; Principal Investigator, Sarah Cannon Research Institute

Physician in Chief, Surgical Oncology, Sarah Cannon

Regional Vice President, Cancer Services for Sarah Cannon at HealthONE, Denver, Colo.

Co-Founder, Sarah Cannon Research Institute

Co-Founder; Principal Investigator, Sarah Cannon Research Institute

Director, Breast Cancer and Gynecologic Cancer Research Program; Principal Investigator, Sarah Cannon Research Institute

Vice President, Business Innovation, Sarah Cannon

Director of Operations, Cardiovascular Research, Sarah Cannon Research Institute

Regional Vice President, Cancer Services for St. David’s Cancer Care, Austin, Texas

Director, Drug Development Program; Principal Investigator, Sarah Cannon Research Institute

Associate Director, Lung Cancer Research, Sarah Cannon Research Institute

Assistant Vice President and Legal Counsel, Sarah Cannon

Senior Director, Scientific Director, Strategic Development; Principal Investigator, Sarah Cannon Research Institute

Physician in Chief, Radiation Oncology, Sarah Cannon; Director, Radiation Oncology Research, Sarah Cannon Research Institute

Regional Vice President, Cancer Services for Sarah Cannon at TriStar Health, Middle Tennessee

Vice President, Legal Counsel; Ethics and Compliance Officer, Sarah Cannon

Senior Director, Corporate Affairs, Sarah Cannon

Regional Vice President, Cancer Services for Sarah Cannon HCA Midwest Health, Kansas City

Director Oncology Strategic Sites, Sarah Cannon Research Institute

Medical Director and Consultant Medical Oncologist, Sarah Cannon Research Institute - UK

President, Development Innovations, Sarah Cannon Research Institute

Senior Investigator, Neuro-Oncology Program; Principal Investigator, Sarah Cannon Research Institute

Senior Director, Global Quality and Education, Sarah Cannon

Director of Early Phase Operations, Drug Development Unit, Sarah Cannon Research Institute

Regional Vice President, Cancer Services for Sarah Cannon at HCA Virginia, Richmond

Vice President, Strategic Development, Sarah Cannon Research Institute

Vice President of Market Operations for Cancer Services, Texas

Assistant Vice President, Radiation Oncology, Sarah Cannon

Senior Investigator, Breast Cancer Research Program; Principal Investigator, Sarah Cannon Research Institute